One of the concerns I discussed above is the possibility that so-called 'compounded' GLP-1 drugs may originate from a kind of biological research machine called a "protein synthesizer" or a "peptide synthesizer" machine
Alarmingly, this trend is growing and increasingly affecting younger populations at an accelerating rate [2]
A clinically positioned GLP-1 metabolic support product provides a credible foundation for building a broader brand ecosystem that may include gut health, muscle preservation, collagen support, energy optimization, and longevity nutrition
For SGLT-2 inhibitors no studies regarding placental transfer were found
Semaglutide works by mimicking a natural hormone (GLP-1) that regulates blood sugar and helps control appetite
Its pretty much the superhero of antioxidants, stepping in to battle those pesky free radicals that can mess with our health